Abstract
Transarterial radioembolization (TARE) is one of the therapeutic options for hepatocellular carcinoma (HCC). This study aimed to investigate the predictors and prognostic values of achieving curative treatments after TARE. Overall, 143 patients with intrahepatic HCC treated with TARE between 2011 and 2017 were recruited from two Korean tertiary institutes. Twenty-seven patients received curative treatments after TARE. Younger age than 65 years and AFP of ≤200 ng/mL independently predicted the increased probability of achieving curative treatment after TARE, and the curative treatment after TARE provided a survival benefit in patients with intrahepatic HCC.
Original language | English |
---|---|
Pages (from-to) | 274-283 |
Number of pages | 10 |
Journal | Cancer Investigation |
Volume | 39 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
Publisher Copyright:© 2021 Taylor & Francis Group, LLC.
All Science Journal Classification (ASJC) codes
- Oncology
- Cancer Research